Curriculum Vitae   Dr. Mayank R. Joshi (M. Pharm., Ph.D)

Aptt#204, 16541 Blatt Blvd, Weston, 33326,  USA Telephone : 1 954 353 0265 Mobile : 1 954 328 6213 Email: [email protected]

 

EDUCATION

 

Doctorate of Philosophy in Pharmacy (Ph.D.),

January 2000, Maharaja Sayajirao University of Baroda, Vadodara, INDIA.

Awarded in April 2002.

 

Master of Pharmacy in Pharmaceutics (73 Percentage, 100 Percentile),

December 1997, Maharaja Sayajirao University of Baroda, Vadodara, INDIA.

Graduate Aptitude Test in Engineering (GATE) 1996 (81.79 Percentile), University Grants Commission Scholarship (Central Government).

 

Bachelor of Pharmacy (65 Percentage, 100 Percentile),

April 1995, Sardar Patel University, Vallabh Vidhyanagar, INDIA.

C. R. Patel's Gold Medal and

G. P. Niars Award (Indian Drug Manufacturer's Association).

 

 

PROFESSIONAL EXPERIENCE (Cumulative about 12+ years)

 

Watson Pharmaceutical Inc., 2945 W. Corporate Lakes Blvd, Weston, Florida  33331 USA.
Director – R & D Formulations, In continuation from 2^nd September 2008.

 

Apotex Inc., 50 Steinway Blvd, Toronto (Etobicoke), Ontario M9W 6Y3 CANADA.
Manager - Full Formulation Development, From 6th September 2005 to 29^th August 2008.

 

Alembic Limited, Alembic Road, Vadodara, INDIA.
Group Leader , Formulation Development, From 1 April 2005 to 12th August 2005
Senior Team Leader (NDDS), Formulation Development, From 1 April 2004 to 31st March 2005 .
Team Leader(NDDS), Formulation Development, From 11th September 2003 to 31st March 2004 .
Assistant Manager, Formulation Development, 13th May 2002 to 9th August 2003.

 

Panacea Biotec Ltd.R&D, Lalru, Punjab, INDIA.
Senior Executive, Formulation Research Division,
Research Associate, Formulation Research Division, Cumulative 6th January 2000 to 30th April 2002.

 

Pharmacy department, Maharaja Sayajirao University of Baroda, Vadodara, INDIA.
Temporary Lecturer, 6th July 1998 to 27th June 1999 and 15th September 99 to 4th January 2000.

 

A. R. College of Pharmacy, Sardar Patel University, Vallabh Vidhyanagar, Gujarat, INDIA,
Lecturer (Ad-hoc), 15th September 1995 to 14th October 1995 and 13th November 1995 to 11th May 1996.

 

Association with Core Parentrals Ltd and Sun Pharmaceuticals Ltd of less than six months is not included.

 

 

CURRENT JOB PROFILE

 

·        Provide technical assistance, mentor and coaches all Formulation staff including Research Scientists, Principal Scientists and Research Fellows, as required. Maintain current technical proficiency and seek out opportunities to expand technical knowledge base. Investigate and propose new or improved processing technologies for consideration and adoption.

 

·        Manage tracking systems for areas of responsibility to meet all established Product Development dates.

 

·        Recruit train and effectively manage the ongoing performance of employees for activities relating to the development of products and processes to supply new submissions according to Watson's Strategic Framework objectives.

 

·        Manage all staff to meet Watson's Strategic Framework objectives while demonstrating corporate values in the performance of their work and in interactions with others and adhering to all Policies, Procedures and cGMPs.

 

·        Propose and submit the departments budget to the Vice President R & D. Manage the budget to produce minimum variances throughout the fiscal year.

 

·        Responsible and accountable for competently supervising subordinates in accordance with the Occupational Health Act, as well as Watson's Health and Safety policies and Safe Work Procedures (SWPs); provide all required training, equipment, tools and follow procedures in accordance with the Safety Charter; attend departmental audits and follow up on corrective actions within prescribed timelines.

 

·        Participate in the development and modification of Processing, safety, and other required training programs.

 

 

FORMULATION DEVELOPMENT EXPOSURE

 

Have acquired major formulation development exposure in the area of Modified and Immediate release tablets and capsules prepared by Direct compression, Dry Granulation and Wet granulation Process. Technologies involved in this developments includes Hydrophilic matrix systems, Hydrophobic matrix systems, Wax based systems, Fluid Bed coated and drug layered pellets, Fluid Bed coated granules, Multi Unit Particulate System (MUPS), Delayed release tablets and Licaps.

 

Have also worked up on development of specialty products like Mouth dissolving tablets, Buccoadhesive tablets, Enhanced activity drug delivery system (Patented Gastro-retentive platform technology), Osmo-microsealed systems (Patented platform technology), osmotic push pull systems, Medicated chewing gums, Wurster coated muccoadhesive particulate system, Dry powder for Reconstitution,  Dry Powder Inhalation and Hydro-alcoholic gels.

 

PATENTS

 

International(PCT)/United States/Canadian/Indian Patent Applications

1.      Extended Release Osmo Microsealed Formulation, WO 2004/108117 and IN 504/Mum/2002.

2.      Extended Release Coated Microtablets of Venlafaxine Hydrochloride, WO 2005/074895, US Appl. 20050169985, IN 980/Mum/2004 and CA 2555295. Patent licensed to Cobalt Inc., of Canada for its generic version of Effexor XR.

3.      Extended Release composition of Levetiracetam, WO 2006/080029, IN 0081/Mum/2005 and US Appl.20060165796. Patent licensed to Belgium-based biopharmaceutical company, UCB Inc. for its Novel Drug Delivery Platform for the latter's Keppra XR, a levetiracetam extended release antiepileptic tablets.

4.      Process of preparing Extended Release composition of Pramipexole Dihydrochloride, WO 2006/046256, IN 1153/Mum/2004 and US Appl.11/260066.

5.      Process and composition of preparing granular Sucralose for emulating table sugar,PCT/IN05/00336, IN 0734/Mum/2005 and US Appl. 20060246197.

6.      A process of preparing tablet dosage form of Azithromycin Monohydrate, IN 621/Mum/2002.

7.      A process of preparing capsule dosage form of Azithromycin Monohydrate, IN 622/Mum/2002.

8.      A process of preparing Modified Release Dosage form of Roxithromycin, IN 276/Mum/2003.

9.      A process of preparing Extended Release Tablets of Clarithromycin, IN 490/Mum/2004.

 

The above mentioned patent applications are in the national phase in other countries of Europe, in Autralia, Japan, Korea, Mexico, New Zealand, Russia, South Africa and China.

 

 

PUBLICATIONS

 

1.      "Disposition Kinetics of Ketotifen from Liposomal Dry Powder for Inhalation in rat lung "Mayank Joshi and Ambikanandhan Misra, Clinical and Experimental Pharmacology and Physiology , 30 (3), 2003, 153-156.

2.      "Pulmonary Disposition of Budesonide from Liposomal Dry Powder Inhaler "Mayank R. Joshi and Ambikanandhan Misra, Methods and Findings in experimental and clinical pharmacology, 23 (12), 2002, 531-536.

3.      " Liposomal Budesonide for Dry Powder Inhaler: Preparation and Stabilization "Mayank R. Joshi and Ambikanandhan Misra, AAPS PharmSciTech , 2 (4), 2001, article 25.

4.      " Dry powder inhalation of liposomal Ketotifen Fumarate : formulation and characterization" M. R. Joshi and A. N. Misra, International journal of pharmaceutics, 223, 2001, 15-27.

5.      "Spectrophotometric Determination of Budesonide." M. R. Joshi and A. N. Misra, Indian Journal of Pharmaceutical Sciences, 62(2) 2000, 92-96.

6.      " Liposomes of terbutaline sulphate - in vitro and in vivo studies." Mayank R. Joshi and A. N. Misra, Indian Journal of Experimental Biology , 37(9) 1999, 881-887.

7.      " Liposomes of terbutaline sulfate: preparation, optimization and stability studies." Mayank R. Joshi and A. N. Misra, Indian Drugs, 36(4) 1999,245-252.

 

 

CONFERENCE AND SEMINARS

 

1.      “FDA Pre-Approval Inspections” International Pharmaceutical Academy, Toronto, CANADA, 23^rd-24^th May 2007.

2.      “Global GMP Update 2006” International Pharmaceutical Academy, Toronto, CANADA, 19-20^th June 2006.

3.      “Current Practices in Solid Dosage Form Processing” Glatt Pharmceutical Services, Ramsey, New Jersy, USA, 16-18^th May 2006.

4.      “Sixth International Symposium on Advances in Technology and Business Potential of New Drug Delivery Systems” Controlled Release Society Indian Chapter, Mumbai, INDIA, 18-19^th February 2005.

5.      "Pulmonary and Nasal Drug Delivery” Indian Pharmaceutical Association, Mumbai, INDIA, 24-25^th March 2004.

6.      “Site Specific Drug Delivery” Pharmaceutical Education and Research Department, Mumbai, INDIA 29^th-31^st January 2003.

7.      CPhI, Frankfurt, GERMANY, 27-29^th October 2003.

8.      “Biotechnology – A Challenge to Pharmacy Profession” 54^th Indian Pharmaceutical Congress 2002, Pune, INDIA, 13-15^th December 2002"Novel drug delivery systems” Center of Relevance and Excellence in New Drug Delivery Systems, M. S. University of Baroda, Vadodara INDIA, 27-28^th May 2002. As a Resource Person.

 

 

ACADEMIC PROJECTS

Ph.D. : " Investigations in liposomal delivery of anti asthmatic drugs "
M. Pharm : " Liposomal formulation of terbutaline sulfate for pulmonary delivery"
B.Pharm : Presented Seminar on," Herbal anti-asthmatic drugs " (Adhatoda vasica & Piper longum)

 

 

EXTRA-CURRICULAR ACTIVITIES

 
National Service Scheme (NSS) : Attended

1. Republic Day Parade Camp. (Jan. 1994), (NATIONAL HONOR)
2. National Integration Cum Pre-Republic Day Parade Camp (Dec. 1993).
3. National Integration Camp, March 1995.

 

Sports Participated in

1. Inter college Badminton (twice) tournament.
2. Inter college Basketball (twice) tournament.
3. Inter college Kabbadi (once) tournament.

 

PERSONAL DETAILS

 

MARITAL STATUS : Married
CHILDRENS : Two Daughter.
DATE OF BIRTH : 09TH Feb, 1974
BLOOD GROUP : "O" Positive
GENER : Male
NATIONALITY : Indian Citizen

RESIDENCE STATUS IN USA : O-1 VISA

Mayank R. Joshi

 

Dated On: 14^th  Feb, 2009

 

REFERENCES (Available upon request)

 

[1] Dr. Yogesh Dandikar,
Address:  Vice President, Research & Development, Paddock Laboratories, Inc. 3940 Quebec Avenue North, Minneapolis, Minnesota 55427. Telephone 1-763-546-4676 Fax: 1-763-546-4842, Mobile 1-763-656-9292 Email: [email protected]

 

[3] Mr. Rajesh Kshirsagar.

Address: Executive Vice President, Micro Labs Ltd., INDIA
Mobile : +91 9972098408. Email: [email protected]

 

[2] Prof. (Dr.) Ambikanandan Misra,
Address:  Professor of Pharmaceutics and Head of Department of Pharmacy, Faculty of Technology & Engineering, The Maharaja Sayajirao University of Baroda, Post Box No.: 51, Kalabhavan, Vadodara - 390 001, Gujarat state, INDIA Telephone no.: +91-265-2434187; Fax no.: +91-265-2418927 Mobile : + 91 9426074870,   Email: [email protected]  [email protected]

[4] Mr. Munish Talwar.

Address: General Manager - Pharma Research, Wockhardt Research Centre, D-4 MIDC Chikalthana, Aurangabad – 431 210, Maharastra, India. Telephone: +91-240-6632222 / 2482590 Mobile: +91 9822249904 Email: [email protected] , [email protected].

[5] Mr. Sampad Bhattacharya.

Address: Vice President Operations, Sun Pharmaceutical Industries Ltd., Halol – Baroda Highway, Halol – 389 350, Gujarat, India. Telephone: +91-2676-220197 / 222446 Email: S[email protected].

 

********